# Cell Free DNA for the Diagnosis and Treatment in Early NSCLC

> **NCT03791034** · — · RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 700 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03791034
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-08-28
- **Primary completion:** 2021-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2021-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03791034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03791034, "Cell Free DNA for the Diagnosis and Treatment in Early NSCLC". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03791034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*